News

Attention-deficit/hyperactivity disorder (ADHD) remains poorly understood from a biological perspective. An international study led by scientists from the Paris Brain Institute and Monash University in Australia suggests that some symptoms may be...

Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...

Artificial intelligence is rapidly transforming the way scientists explore the human brain. To accelerate breakthroughs, the Paris Brain Institute is launching, after its Call for Junior Group Leaders, a Call for Expression of Interest for Senior or...

Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...

Violetta Zujovic is team leader and scientific manager of the facility. Her research focuses on the immune system’s role in myelin repair, which is a key factor in neurological disorders such as multiple sclerosis and certain leukodystrophies. With...

Paris Brain Institute is co-organizing the 3rd edition of the “Modeling Human Neuropathologies” Summer School, together with the Interdisciplinary Center for Neurosciences (University of Heidelberg). The summer school is an intensive international...

An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...

The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...

There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...

The Paris Brain Institute is launching a Call for Junior Group Leaders, inviting outstanding early-career scientists in artificial intelligence, data science, computational neuroscience, and related fields to establish their own independent research...

In January 2026, Paris Brain Institute organized the World Brain Health Forum, an international event that was at the heart of its 15th anniversary celebrations. Over three days, from January 14 to 16, around 80 international speakers and more than 1...

The Ban Ki-moon Foundation, the Paris Brain Institute, and the Vascular Brain Health Institute signed a new partnership agreement marking a major step to championing brain health, building local capacity, and specialized education to launch the...